EUVIMEDEUVIMED entdecken
Crossref

Vitamin B6 Modification of Bovine Pericardial Bioprosthetic Heart Valve Leaflets Promotes Blood Outgrowth Endothelial Cell Adhesion

Tina E Thomas iD, Sachin Aryal iD, Andrey Zakharchenko, Alexis Martinez iD, Stanley J Stachelek iD, Giovanni Ferrari iD, Robert J Levy iD

Journal of Biomedical Materials Research Part A · 2026

DOI: 10.1002/jbm.a.70175 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part A, 2026. Verfasst von Tina E Thomas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, School of Engineering and Applied Science, The University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Pericardium, Endothelial Cells, Heart Valve Prosthesis, Pyridoxamine. Die Arbeit nennt 29 Literaturangaben. Gefördert von: NIH HHS, The Kibel Fund for Aortic Valve Research, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bioprosthetic heart valves (BHV), typically fabricated from glutaraldehyde‐fixed bovine pericardium (BP), are the most common type of replacement for patients with severe heart valve disease. Despite being preferred, BHV are limited in durability due to structural valve degeneration (SVD), which occurs due to leaflet calcification and non‐calcific mechanisms including advanced glycation end product (AGE) accumulation and serum protein infiltration. Another limitation of BHV is characteristically they do not endothelialize, even after years of implantation. Previously we showed pretreating BP with Pyridoxamine (PYR), a vitamer of vitamin B6, effectively mitigated AGE accumulation in vitro and in vivo. The present studies investigated the effect of PYR pretreated BHV on endothelial cell‐material interactions, using bone marrow origin human blood outgrowth endothelial cells (BOEC) as a model cell type; the hypothesis was PYR pretreatment would provide a more favorable surface for endothelialization compared to glut‐fixed BP. Static studies compared untreated BP versus PYR‐BP to examine the effect on cell adhesion; PYR‐BP had significantly more BOEC adhered than untreated BP measured by Alamar blue assays. PYR pretreatment under non‐AGE and model AGE conditions were also investigated via static and high shear studies. PYR pretreated collagen coated‐glutaraldehyde fixed slides significantly increased BOEC attachment over time under AGE and non‐AGE conditions. Under arterial shear levels, PYR pretreatment increased BOEC retention compared to untreated slides under non‐AGE and AGE conditions. In conclusion, PYR pretreated BP or model, thin‐layer collagen surfaces promote endothelial cell attachment and reduced cytotoxicity under static and shear conditions, with or without AGE presence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PericardiumEndothelial CellsHeart Valve ProsthesisPyridoxamineBioprosthesisVitamin B 6AnimalsCell AdhesionCattleHumansGlycation End Products, AdvancedAntiglycation Agents

Stichwörter der Autor:innen

bioprosthetic heart valvesendothelial cellsglycationpyridoxamine

Substanzen

PyridoxamineVitamin B 6Glycation End Products, AdvancedAntiglycation Agents

Autor:innen und Institutionen

  • Department of Bioengineering, School of Engineering and Applied Science, The University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • The Topolewski Pediatric Heart Valve Center, Division of Cardiology, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Departments of Surgery and Biomedical Engineering, Columbia University, New York, New York, USA.

ORCID-Profile: Tina E Thomas, Sachin Aryal, Alexis Martinez, Stanley J Stachelek, Giovanni Ferrari, Robert J Levy

Förderung

  • NIH HHS
  • The Kibel Fund for Aortic Valve Research
  • NHLBI NIH HHS
  • Erin's Fund
  • William J Rashkind Endowment of the Children's Hospital of Philadelphia
  • National Institutes of Health

Zitieren

APA

Thomas, T. E., Aryal, S., Zakharchenko, A., Martinez, A., Stachelek, S. J., Ferrari, G., & Levy, R. J. (2026). Vitamin B6 Modification of Bovine Pericardial Bioprosthetic Heart Valve Leaflets Promotes Blood Outgrowth Endothelial Cell Adhesion. Journal of Biomedical Materials Research Part A. https://doi.org/10.1002/jbm.a.70175

Vancouver

Thomas TE, Aryal S, Zakharchenko A, Martinez A, Stachelek SJ, Ferrari G, et al. Vitamin B6 Modification of Bovine Pericardial Bioprosthetic Heart Valve Leaflets Promotes Blood Outgrowth Endothelial Cell Adhesion. Journal of Biomedical Materials Research Part A. 2026. doi:10.1002/jbm.a.70175

BibTeX
@article{Thomas2026,
  author = {Thomas, Tina E and Aryal, Sachin and Zakharchenko, Andrey and Martinez, Alexis and Stachelek, Stanley J and Ferrari, Giovanni and Levy, Robert J},
  title = {Vitamin B6 Modification of Bovine Pericardial Bioprosthetic Heart Valve Leaflets Promotes Blood Outgrowth Endothelial Cell Adhesion},
  journal = {Journal of Biomedical Materials Research Part A},
  year = {2026},
  doi = {10.1002/jbm.a.70175}
}
Kostenlos starten →